Literature DB >> 16199154

The Fos family of transcription factors and their role in tumourigenesis.

Karin Milde-Langosch1.   

Abstract

Members of the Fos family (c-Fos, FosB and its smaller splice variants, Fra-1 and Fra-2) dimerise with Jun proteins to form the AP-1 transcription factor complex. Based on the rapidly growing amount of data from experimental studies, animal models and investigations on clinical tumour samples, this review summarises the current knowledge about the role of these proteins in carcinogenesis. In addition to c-Fos, which has oncogenic activity and is frequently overexpressed in tumour cells, Fra-1 seems to play a role in the progression of many carcinomas. The results obtained from various studies show different implications for these transcription factors according to tumour type, i.e., Fra-1 overexpression enhances the motility and invasion of breast and colorectal cancer cells, but inhibits the tumourigenicity of cervical carcinoma cell lines. Knowledge about regulation of invasion and metastasis in different malignant tumours in vivo might open promising perspectives to targeted therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199154     DOI: 10.1016/j.ejca.2005.08.008

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  206 in total

Review 1.  Cell invasion through basement membrane: the anchor cell breaches the barrier.

Authors:  Elliott J Hagedorn; David R Sherwood
Journal:  Curr Opin Cell Biol       Date:  2011-05-31       Impact factor: 8.382

2.  Gossypol inhibits growth, invasiveness, and angiogenesis in human prostate cancer cells by modulating NF-κB/AP-1 dependent- and independent-signaling.

Authors:  Jiahua Jiang; Veronika Slivova; Andrej Jedinak; Daniel Sliva
Journal:  Clin Exp Metastasis       Date:  2011-12-14       Impact factor: 5.150

3.  Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription.

Authors:  Wei-Ming Wang; Shwu-Yuan Wu; A-Young Lee; Cheng-Ming Chiang
Journal:  J Biol Chem       Date:  2011-09-21       Impact factor: 5.157

4.  RGS16 and FosB underexpressed in pancreatic cancer with lymph node metastasis promote tumor progression.

Authors:  Ji Hyang Kim; Jin Young Lee; Kyu Taek Lee; Jong Kyoon Lee; Kwang Hyuck Lee; Kee-Taek Jang; Jin Seok Heo; Seong Ho Choi; Jong Chul Rhee
Journal:  Tumour Biol       Date:  2010-06-23

5.  12 Arylstibonic acids that inhibit the DNA binding of five B-ZIP dimers.

Authors:  Vikas Rishi; Won-Jun Oh; Sarah L Heyerdahl; Jianfei Zhao; Dominic Scudiero; Robert H Shoemaker; Charles Vinson
Journal:  J Struct Biol       Date:  2010-02-20       Impact factor: 2.867

Review 6.  Chemokines: novel targets for breast cancer metastasis.

Authors:  Simi Ali; Gwendal Lazennec
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

7.  A delayed antioxidant response in heat-stressed cells expressing a non-DNA binding HSF1 mutant.

Authors:  Sanne M M Hensen; Lonneke Heldens; Siebe T van Genesen; Ger J M Pruijn; Nicolette H Lubsen
Journal:  Cell Stress Chaperones       Date:  2013-01-16       Impact factor: 3.667

8.  Profiling of zinc-altered gene expression in human prostate normal vs. cancer cells: a time course study.

Authors:  Shu-Fei Lin; Hua Wei; Dennis Maeder; Renty B Franklin; Pei Feng
Journal:  J Nutr Biochem       Date:  2008-12-13       Impact factor: 6.048

9.  HGF mediates cell proliferation of human mesothelioma cells through a PI3K/MEK5/Fra-1 pathway.

Authors:  Maria E Ramos-Nino; Steven R Blumen; Tara Sabo-Attwood; Harvey Pass; Michele Carbone; Joseph R Testa; Deborah A Altomare; Brooke T Mossman
Journal:  Am J Respir Cell Mol Biol       Date:  2007-09-13       Impact factor: 6.914

10.  Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma.

Authors:  Naoshad Muhammad; Sourav Bhattacharya; Robert Steele; Nancy Phillips; Ratna B Ray
Journal:  Clin Cancer Res       Date:  2016-12-13       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.